HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor necrosis factor-alpha, an initiator, and etanercept, an inhibitor of cochlear inflammation.

AbstractOBJECTIVES/HYPOTHESIS:
The inner ear rapidly mounts an immune response that can lead to cochlear degeneration and permanent hearing loss. Identification of proinflammatory cytokine expression during the initiation of the response should lead to rational therapeutic strategies that block the response, reducing damaging sequelae.
STUDY DESIGN:
A cochlear immune response to keyhole limpet hemocyanin (KLH) injected into the inner ear or subarachnoid space of sensitized animals was created. Etanercept was administered to a group of animals to blunt the immune response.
METHODS:
Cochleae were immunoassayed for expression of interleukin-1beta, tumor necrosis factor-alpha, and interleukin-6 and evaluated for the amount of cochlear-infiltrated cells.
RESULTS:
Tumor necrosis factor-alpha and interleukin-1beta were expressed by infiltrated cells shortly after KLH injection. Tumor necrosis factor-alpha was expressed whether the antigen was introduced with or without surgical trauma. Interleukin-1beta was also expressed by the cochlear fibrocytes during the immune response and in surgical control animals, but not after intrathecal injection of antigen. Interleukin-6 expression was minimal during the response. Based on this observation, animals were treated with systemic injection of Etanercept, which reduced cochlear infiltrating cell number and cochlear fibrosis.
CONCLUSION:
Interleukin-1beta expression is a general cochlear response to trauma, whereas tumor necrosis factor-alpha expression in the infiltrated immunocompetent cells is the cytokine that induces amplification of the response that leads to cochlear disease.
AuthorsHitoshi Satoh, Gary S Firestein, Peter B Billings, Jeffrey P Harris, Elizabeth M Keithley
JournalThe Laryngoscope (Laryngoscope) Vol. 112 Issue 9 Pg. 1627-34 (Sep 2002) ISSN: 0023-852X [Print] United States
PMID12352677 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Interleukin-1
  • Interleukin-6
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Hemocyanins
  • Etanercept
Topics
  • Animals
  • Cochlea (immunology, metabolism)
  • Etanercept
  • Female
  • Hemocyanins (immunology)
  • Immunoglobulin G (pharmacology)
  • Immunosuppressive Agents (pharmacology)
  • Interleukin-1 (metabolism)
  • Interleukin-6 (metabolism)
  • Mice
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: